Format
Sort by
Items per page

Send to

Choose Destination

Best matches for bipolar disorder AND cessation of smoking AND mental disorders AND smoking:

Search results

Items: 1 to 20 of 91

1.

The Use of Zonisamide for the Treatment of Psychiatric Disorders: A Systematic Review.

Buoli M, Grassi S, Ciappolino V, Serati M, Altamura AC.

Clin Neuropharmacol. 2017 Mar/Apr;40(2):85-92. doi: 10.1097/WNF.0000000000000208. Review.

PMID:
28195838
2.

The Epidemiology of DSM-5 Nicotine Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III.

Chou SP, Goldstein RB, Smith SM, Huang B, Ruan WJ, Zhang H, Jung J, Saha TD, Pickering RP, Grant BF.

J Clin Psychiatry. 2016 Oct;77(10):1404-1412. doi: 10.4088/JCP.15m10114.

PMID:
27135834
3.

The Development and Implementation of an Electronic Health Record Tool for Monitoring Metabolic Syndrome Indices in Patients with Serious Mental Illness.

Nash K, Ghinassi F, Brar JS, Alam A, Bohan MC, Gopalan K, Carter A, Chengappa KN.

Clin Schizophr Relat Psychoses. Fall 2016;10(3):145-153.

PMID:
27732099
4.

Smokers with Self-Reported Mental Health Conditions: A Case for Screening in the Context of Tobacco Cessation Services.

Tedeschi GJ, Cummins SE, Anderson CM, Anthenelli RM, Zhuang YL, Zhu SH.

PLoS One. 2016 Jul 8;11(7):e0159127. doi: 10.1371/journal.pone.0159127. eCollection 2016.

5.

It is feasible and effective to help patients with severe mental disorders to quit smoking: An ecological pragmatic clinical trial with transdermal nicotine patches and varenicline.

Garcia-Portilla MP, Garcia-Alvarez L, Sarramea F, Galvan G, Diaz-Mesa E, Bobes-Bascaran T, Al-Halabi S, Elizagarate E, Iglesias C, Saiz Martínez PA, Bobes J.

Schizophr Res. 2016 Oct;176(2-3):272-280. doi: 10.1016/j.schres.2016.05.011. Epub 2016 May 26.

PMID:
27237598
6.

Weight gain and 10-year cardiovascular risk with sustained tobacco abstinence in smokers with serious mental illness: a subgroup analysis of a randomized trial.

Thorndike AN, Achtyes ED, Cather C, Pratt S, Pachas GN, Hoeppner SS, Evins AE.

J Clin Psychiatry. 2016 Mar;77(3):e320-6. doi: 10.4088/JCP.15m10074.

PMID:
27046320
7.

Development, acceptability and efficacy of a standardized healthy lifestyle intervention in recurrent depression.

Goracci A, Rucci P, Forgione RN, Campinoti G, Valdagno M, Casolaro I, Carretta E, Bolognesi S, Fagiolini A.

J Affect Disord. 2016 May 15;196:20-31. doi: 10.1016/j.jad.2016.02.034. Epub 2016 Feb 11.

PMID:
26897454
8.

A comparison of neuropsychiatric adverse events during early treatment with varenicline or a nicotine patch.

Cunningham FE, Hur K, Dong D, Miller DR, Zhang R, Wei X, McCarren M, Mosholder AD, Graham DJ, Aspinall SL, Good CB.

Addiction. 2016 Jul;111(7):1283-92. doi: 10.1111/add.13329. Epub 2016 Apr 15.

PMID:
26826702
9.

The safety of treatments for tobacco use disorder.

Little MA, Ebbert JO.

Expert Opin Drug Saf. 2016;15(3):333-41. doi: 10.1517/14740338.2016.1131817. Epub 2015 Dec 30. Review.

PMID:
26715118
10.

Mortality in schizophrenia and bipolar disorder: Clinical and serological predictors.

Dickerson F, Origoni A, Schroeder J, Schweinfurth LA, Stallings C, Savage CL, Katsafanas E, Banis M, Khushalani S, Yolken R.

Schizophr Res. 2016 Jan;170(1):177-83. doi: 10.1016/j.schres.2015.11.010. Epub 2015 Nov 20.

PMID:
26607103
11.

Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis.

Roberts E, Eden Evins A, McNeill A, Robson D.

Addiction. 2016 Apr;111(4):599-612. doi: 10.1111/add.13236. Epub 2016 Jan 19. Review.

12.

[Hypomania following the use of varenicline in two patients with bipolar disorder].

Sluys ML, Remmers A, Beerthuis RJ.

Tijdschr Psychiatr. 2015;57(11):835-8. Dutch.

13.

Smoking cessation and reduction in people with chronic mental illness.

Tidey JW, Miller ME.

BMJ. 2015 Sep 21;351:h4065. doi: 10.1136/bmj.h4065. Review.

14.

A combined analysis of worldwide studies demonstrates an association between bipolar disorder and tobacco smoking behaviors in adults.

Jackson JG, Diaz FJ, Lopez L, de Leon J.

Bipolar Disord. 2015 Sep;17(6):575-97. doi: 10.1111/bdi.12319. Epub 2015 Aug 4. Review.

PMID:
26238269
15.

Interventions to Address Medical Conditions and Health-Risk Behaviors Among Persons With Serious Mental Illness: A Comprehensive Review.

McGinty EE, Baller J, Azrin ST, Juliano-Bult D, Daumit GL.

Schizophr Bull. 2016 Jan;42(1):96-124. doi: 10.1093/schbul/sbv101. Epub 2015 Jul 28. Review.

16.

Treating Tobacco Dependence at the Intersection of Diversity, Poverty, and Mental Illness: A Randomized Feasibility and Replication Trial.

Hickman NJ 3rd, Delucchi KL, Prochaska JJ.

Nicotine Tob Res. 2015 Aug;17(8):1012-21. doi: 10.1093/ntr/ntv034.

17.

Dr Chengappa and colleagues reply.

Chengappa KN, Perkins KA, Brar JS, Turkin SR, Levine MD, George TP.

J Clin Psychiatry. 2015 May;76(5):625-6. doi: 10.4088/JCP.14lr09456a. No abstract available.

18.

Varenicline for smoking cessation in the bipolar patient.

Tofler IR.

J Clin Psychiatry. 2015 May;76(5):625. doi: 10.4088/JCP.14lr09456. No abstract available.

19.

Tobacco use in bipolar disorder.

Thomson D, Berk M, Dodd S, Rapado-Castro M, Quirk SE, Ellegaard PK, Berk L, Dean OM.

Clin Psychopharmacol Neurosci. 2015 Apr 30;13(1):1-11. doi: 10.9758/cpn.2015.13.1.1.

20.

Acceptance and Commitment Therapy and nicotine patch for smokers with bipolar disorder: preliminary evaluation of in-person and telephone-delivered treatment.

Heffner JL, McClure JB, Mull KE, Anthenelli RM, Bricker JB.

Bipolar Disord. 2015 Aug;17(5):560-6. doi: 10.1111/bdi.12300. Epub 2015 Apr 25.

Supplemental Content

Loading ...
Support Center